|
| n-Ffold (±SEM)b | Gene symbol | Functionc | Spot no. | Matching scored |
Proteina | T-Huh7e | C-Huh7f | | | T-Huh7 | C-Huh7 | T-Huh7 | C-Huh7 |
|
| | | | Regulation of cell proliferation and structure | | | | |
|
Vimentin* | 5 ± 0.01 | 3.6 ± 0.02 | VIM | | 17 | 11 | 2228 | 1827 |
Vimentin* | 3 ± 0.03 | 2.3 ± 0.1 | VIM | | 18 | 12 | 2166 | 1490 |
Tubulin beta | 0.4 ± 0.3 | 2.7 ± 0.3 | TUBB | | 14 | 21 | 112 | 962 |
Tubulin beta* | NI | 2.4 ± 0.5 | TUBB | | — | 45 | — | 341 |
Transmembrane protein 4 | 4.5 ± 0.04 | NI | CNPY2 | | 51 | — | 338 | — |
Stomatin-like 2 | NI | 2.4 ± 0.3 | SLP2 | Cytoskeleton and structural organization | — | 10 | — | 1272 |
Beta actin | NI | 2.35 ± 0.04 | ACTB | | — | 24 | — | 560 |
Mutant beta-actin* | 2.7 ± 0.01 | NI | ACTB | | 20 | — | 166 | — |
Mutant beta-actin* | 2.1 ± 0.3 | NI | ACTB | | 38 | — | 161 | — |
Actin related protein 2/3 complex, subunit 5-like | 2.2 ± 0.1 | 0.4 ± 0.1 | ARPC5 | | 47 | 40 | 181 | 422 |
Stathmin 1 | 0.3 ± 0.1 | 3.2 ± 0.02 | STMN1 | | 46 | 39 | 536 | 322 |
|
Integrin beta 4 binding protein isoform a | 0.3 ± 0.01 | NI | ITGB4 | Cell-matrix adhesion | 33 | — | 139 | — |
Ran-binding protein 1 | 0.4 ± 0.1 | NI | RAN-BP1 | 31 | — | 147 | — |
|
| | | | Metabolism and Biosynthesis enzymes | | | | |
|
Malate dehydrogenase | 0.4 ± 0.1 | NI | MDHA | | 10 | — | 451 | — |
Enolase* | 2.1 ± 0.3 | NI | ENO | | 23 | — | 782 | — |
Enolase* | 4.2 ± 0.02 | NI | ENO | Energy metabolism | 53 | — | 800 | — |
Triosephosphate isomerase 1 | 2.1 ± 0.3 | 2.6 ± 0.3 | TIM | | 26 | 34 | 1115 | 1210 |
ATP synthase beta sub unit | 3.5 ± 0.2 | 2.4 ± 0.2 | ATP5B | | 9 | 36 | 75 | 423 |
ATP synthase, H+ transporting mitochondrial F0 complex sub unit d isoform a | 2.1 ± 0.3 | NI | ATP5H | | 35 | — | 139 | — |
|
UV excision repair protein RAD23 homolog B | 2.1 ± 0.1 | NI | RAD23B | Nucleic acid metabolism (DNA repair) | 16 | — | 889 | — |
Enoyl coenzyme A hydratase 1, peroxisomal | 4.8 ± 0.01 | NI | ECH1 | Fatty acid metabolism | 24 | — | 549 | — |
Tryptophan 5-monooxygenase activation protein | NI | 2.7 ± 0.3 | YWHAQ | Amino acid metabolism | — | 27 | — | 609 |
Selenophosphate synthetase | NI | 4.3 ± 0.02 | SEPHS1 | — | 8 | — | 584 |
Pyrophosphatase 1 | NI | 3.7 ± 0.01 | PPA1 | Nucleotide metabolism | — | 22 | — | 201 |
|
| | | | Protein translation, Modification, and Degredation | | | | |
|
Heterogeneous nuclear ribonucleoprotein | NI | 3.4 ± 0.03 | HNRP | RNA processing | — | 6 | — | 870 |
|
Valosin-containing protein* | 0.4 ± 0.1 | NI | VCP | | 1 | — | 3218 | — |
Valosin-containing protein* | 0.2 ± 0.1 | NI | VCP | | 2 | — | 2178 | — |
Valosin-containing protein* | 0.4 ± 0.1 | NI | VCP | | 3 | — | 1318 | — |
Prefoldin subunit 2 | 3.8 ± 0.02 | 2.9 ± 0.1 | PFDN2 | | 43 | 38 | 378 | 299 |
Cathepsin D preprotein | 2.7 ± 0.3 | 2.2 ± 0.3 | CTSD | | 27 | 9 | 370 | 615 |
Ubiquitin-conjugating enzyme E2N | 0.4 ± 0.3 | NI | UBE2N | | 44 | — | 230 | — |
Ubiquilin 1* | 2.4 ± 0.01 | NI | UBQLN1 | | 12 | — | 116 | — |
Ubiquilin 1* | 2.1 ± 0.3 | NI | UBQLN1 | Protein degradation | 13 | — | 602 | — |
Ubiquitin carboxy-terminal hydrolase L1 | 0.3 ± 0.1 | NI | UCHL1 | | 30 | — | 230 | — |
Ubiquitin carboxyl-terminal esterase L3 | NI | 2.5 ± 0.06 | UCHL3 | | — | 29 | — | 320 |
S-phase kinase-associated protein 1A isoform b | 3.2 ± 0.05 | NI | SKP1 | | 42 | — | 124 | — |
Proteasome alpha 3 subunit isoform 1 | 2.1 ± 0.3 | 4.1 ± 0.01 | PSMA3 | | 52 | 26 | 63 | 71 |
Proteasome 26S non-ATPase subunit 4 | 2.5 ± 0.1 | NI | PSMA4 | | 15 | — | 599 | — |
Prolyl 4-hydroxylase, alpha 1 subunit isoform 2 precursor | NI | 2.5 ± 0.03 | P4HA1 | | — | 5 | — | 888 |
Heme binding protein 2 | 2.8 ± 0.01 | NI | HEBP2 | | 32 | — | 107 | — |
Small glutamine-rich tetratricopeptide | NI | 0.1 ± 0.01 | SGTA | | — | 20 | — | 403 |
|
Eukaryotic translation initiation factor 3 | 3.0 ± 0.02 | NI | EIF3A | | 22 | — | 994 | — |
Eukaryotic translation initiation factor 5A* | 2.7 ± 0.1 | 2.3 ± 0.05 | EIF5A | | 49 | 44 | 542 | 253 |
Eukaryotic translation initiation factor 5A* | 2.8 ± 0.1 | NI | EIF5A | Protein translation, modification, and elongation activity | 50 | — | 147 | — |
Eukaryotic translation elongation factor 1 delta isoform 2 | NI | 2.2 ± 0.4 | EEF2D | | — | 18 | — | 627 |
Eukaryotic translation elongation factor 1 delta isoform 1 | NI | 0.4 ± 0.1 | EEF1D | | — | 19 | — | 565 |
Human pre-mRNA splicing factor | NI | 2.1 ± 0.2 | SF2 | | — | 37 | — | 61 |
|
Mitochondrial ribosomal protein L7L12* | NI | 2.1 ± 0.4 | MRPL17 | Ribosomal structure, and biogenesis | — | 42 | — | 164 |
Mitochondrial ribosomal protein L7L12* | NI | 2.4 ± 0.1 | MRPL17 | — | 43 | — | 86 |
|
| | | | Regulation of transcription | | | | |
|
Basic transcription factor 3-like 4 | 0.4 ± 0.5 | NI | BTF3L4 | DNA binding | 36 | — | 106 | — |
WD repeat domin 77 | NI | 2.5 ± 0.03 | WDR | Coordination of multiprotein complex assemblies | — | 14 | — | 166 |
|
| | | | Stress response | | | | |
|
Mitochondria heat shock protein 75* | 2.3 ± 0.2 | 2.7 ± 0.1 | DnaK | | 4 | 1 | 1817 | 3016 |
Mitochondria heat shock protein 75* | 2.7 ± 0.5 | 3.1 ± 0.1 | DnaK | | 5 | 2 | 1817 | 2383 |
Heat shock 70 kDa protein 8 isoform 1* | 2.9 ± 0.1 | 2.3 ± 0.3 | HSPA8 | Heat shock proteins and chaperones | 6 | 3 | 2463 | 2383 |
Heat shock 70 kDa protein 8 isoform 1* | 2.6 ± 0.1 | 2.7 ± 0.1 | HSPA8 | | 7 | 4 | 1822 | 1792 |
Chaperonin | 2.3 ± 0.2 | NI | Cpn60 | | 21 | — | 1361 | — |
T-complex polypeptide 1 (chaperonin) | 0.15 ± 0.01 | NI | TCP1 | | 8 | — | 336 | — |
|
Superoxide dismutase copper chaperone | 0.35 ± 0.2 | NI | HMA | Oxidative stress response | 25 | — | 203 | — |
Cu/Zn superoxide dismutase | 0.2 ± 0.03 | NI | CuZnSOD | 37 | — | 69 | — |
|
Peroxiredoxin 2 isoform a | 2.4 ± 0.05 | 2.7 ± 0.2 | PRDX2 | | 34 | 35 | 564 | 78 |
Peroxiredoxin 3 isoform a precursor | NI | 2.5 ± 0.1 | PRDX3 | Thio-specific antioxidant protein | — | 31 | — | 179 |
Peroxiredoxin 4 | NI | 3.2 ± 0.05 | PRDX4 | | — | 30 | — | 782 |
|
Thioredoxin-like 1 | NI | 0.37 ± 0.1 | TXNL1 | Oxidoreductase activity | — | — | 17 | 758 |
Endoplasmic reticulum thioredoxin superfamily member | 4.7 ± 0.01 | NI | TXNDC12 | 48 | — | 112 | — |
|
CGI-150 protein | NI | 2.1 ± 0.1 | CGI | Response to toxin | — | 23 | — | 521 |
|
| | | | Signal transduction and transport | | | | |
|
Progesterone receptor membrane component 1* | 0.3 ± 0.2 | NI | PGRMC1 | | 40 | — | 322 | — |
Progesterone receptor membrane component 1* | 0.35 ± 0.4 | NI | Signal transduction | 41 | — | 294 | — |
Phospholipase C-alpha | 0.3 ± 0.03 | NI | PLCα | | 19 | — | 227 | — |
Glia maturation factor, beta | NI | 2.8 ± 0.01 | GMFB | | — | 41 | — | 233 |
|
Sorcine isoform a | 3.1 ± 0.01 | NI | SRI | Transmembrane transporter protein | 39 | — | 320 | — |
Calcium-binding mitochondrial carrier | NI | 0.2 ± 0.01 | EFH | — | 7 | — | 242 |
|
| | | | Tumour-related | | | | |
|
Tumor protein D52-like 2 isoform f | 3.7 ± 0.03 | NI | TPD52 | Tumorigenesis | 29 | — | 63 | — |
Hepatoma-derived growth factor | NI | 2.9 ± 0.01 | HDGF | Cellular proliferation and differentiation | — | 13 | — | 65 |
Transformation upregulated nuclear protein | 4.2 ± 0.01 | NI | HNRNP-K | 54 | — | 116 | — |
|
Rho GDP dissociation inhibitor alpha | NI | 2.3 ± 0.2 | GDI | | — | 28 | — | 412 |
C-myc binding protein | 0.3 ± 0.03 | NI | MM1 | | 45 | — | 159 | — |
RAS related protein | NI | 3.1 ± 0.1 | RAB33 | | — | 33 | — | 147 |
Immunity-related GTPase | 3.0 ± 0.3 | NI | IRGQ | Oncogene related | 11 | — | 125 | — |
B23 nucleophosmin* | NI | 2.9 ± 0.1 | NPM | | — | 15 | — | 1065 |
B23 nucleophosmin* | NI | 3.2 ± 0.1 | NPM | | — | 16 | — | 1091 |
DJ-1 protein | NI | 0.2 ± 0.01 | DJ-1 | | — | 32 | — | 429 |
|
Prohibitin | NI | 3.2 ± 0.1 | PHB | Negative regulator of apoptosis | — | 25 | — | 59 |
|